Organogenesis Holdings Inc Class A ORGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $2.67
- Day Range
- $2.58–2.69
- 52-Week Range
- $2.04–7.08
- Bid/Ask
- $2.45 / $2.70
- Shares Outstanding
- 128.67M
- Market Cap
- $337.13M
- Volume/Avg
- 542,806 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 8.60
- Price/Sales
- 0.67
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 854
- Website
- https://www.organogenesis.com
Valuation
|
Metric
|
ORGO
|
|---|---|
Price/Earnings (Normalized) | 8.60 |
Price/Book Value | 1.38 |
Price/Sales | 0.67 |
Price/Cash Flow | 4.77 |
Price/Earnings
ORGO
Financial Strength
|
Metric
|
ORGO
|
|---|---|
Quick Ratio | 2.74 |
Current Ratio | 3.53 |
Interest Coverage | — |
Quick Ratio
ORGO
Profitability
|
Metric
|
ORGO
|
|---|---|
Return on Assets (Normalized) | 4.87% |
Return on Equity (Normalized) | 9.75% |
Return on Invested Capital (Normalized) | 5.39% |
Return on Assets
ORGO
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|pf%$sSm | LOCK|KDSm! | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|gY%bsR> | LOCK|CK& | $44B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|HvJC<Ly# | LOCK|!?>G | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|S@cf?#mD | LOCK|wmV | $32B | |||
| Viatris Inc
VTRS
| LOCK|NKb>>@ | LOCK|y< | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|DF | LOCK|Y%# | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|R%bkKS | LOCK|h^G | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|$mW^K# | LOCK|&& | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|&><Hs@z | LOCK|pxcQ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|nVFp&@ | LOCK|sM | $1B |
United States